Mark Williams

Mark Williams

Auto-generated profile, based on publicly available information

Mark Williams

Genomic Diagnostics, Melbourne, Australia

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2017 in BMC Genomics
Verified
Journal Article
Open access
PDF file
CWCamilla J. Williams
Camilla J. Williams
MWMark G. Williams
Mark G. Williams
NENir Eynon
Nir Eynon
KAKevin Ashton
Kevin Ashton
JLJonathan Little
Jonathan Little
JCJeff S. Coombes
Jeff S. Coombes
Cardiorespiratory fitness (VO2max) is an excellent predictor of chronic disease morbidity and mortality risk. Guidelines recommend individuals undertake exercise training to improve VO2max for chronic disease reduction. However, there are large inter-individual differences between exercise training responses. This systematic review is aimed at identifying genetic variants that are associated with VO2max trainability. Peer-reviewed research papers published up until October 2016 from four databases were examined. Articles were included if they examined genetic variants, incorporated a supervised aerobic exercise intervention; and measured VO2max/VO2peak pre and post-intervention. Thirty-five articles describing 15 cohorts met the criteria for inclusion. The majority of studies used a cross-sectional retrospective design. Thirty-two studies researched candidate genes, two used Genome-Wide Association Studies (GWAS), and one examined mRNA gene expression data, in addition to a GWAS. Across these studies, 97 genes to predict VO2max trainability were identified. Studies found phenotype to be dependent on several of these genotypes/variants, with higher responders to exercise training having more positive response alleles than lower responders (greater gene predictor score). Only 13 genetic variants were reproduced by more than two authors. Several other limitations were noted throughout these studies, including the robustness of significance for identified variants, small sample sizes, limited cohorts focused primarily on Caucasian populations, and minimal baseline data. These factors, along with differences in exercise training programs, diet and other environmental gene expression mediators, likely influence the ideal traits for VO2max trainability. Ninety-seven genes have been identified as possible predictors of VO2max trainability. To verify the strength of these findings and to identify if there are more genetic variants and/or mediators, further tightly-controlled studies that measure a range of biomarkers across ethnicities are required.

1 April 2019 in Genetics in Medicine
Verified
Journal Article
Closed access
PDF file
JKJoanna Kennedy
Joanna Kennedy
DGDavid Goudie
David Goudie
EBEdward Blair
Edward Blair
KCKate Chandler
Kate Chandler
SJShelagh Joss
Shelagh Joss
RNRuth Newbury-Ecob
Ruth Newbury-Ecob

24 June 2019 in Nature Neuroscience
Verified
Journal Article
Closed access
PDF file
RTRossella Avagliano Trezza
Rossella Avagliano Trezza
MSMonica Sonzogni
Monica Sonzogni
SBStijn N. V. Bossuyt
Stijn N. V. Bossuyt
FZF. Isabella Zampeta
F. Isabella Zampeta
APA. Mattijs Punt
A. Mattijs Punt
YEYpe Elgersma
Ype Elgersma

1 October 2012 in Pathology
Verified
Journal Article
Closed access
PDF file
JAJane E. Armes
Jane E. Armes
IMIvan McGown
Ivan McGown
MWMark Williams
Mark Williams
ABAmy Broomfield
Amy Broomfield
KGKaren Gough
Karen Gough
RLRohan Lourie
Rohan Lourie

19 February 2021 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
SBStijn N V Bossuyt
Stijn N V Bossuyt
APA Mattijs Punt
A Mattijs Punt
IGIlona J de Graaf
Ilona J de Graaf
JBJanny van Den Burg
Janny van Den Burg
MWMark G Williams
Mark G Williams
BDBen Distel
Ben Distel
Angelman syndrome (AS) is a severe neurodevelopmental disorder caused by deletion (~75%) or mutation (~10%) of the ubiquitin E3 ligase A (UBE3A) gene, which encodes a HECT type E3 ubiquitin protein ligase. Although the critical substrates of UBE3A are unknown, previous studies have suggested a critical role of nuclear UBE3A in AS pathophysiology. Here, we investigated to what extent UBE3A missense mutations disrupt UBE3A subcellular localization as well as catalytic activity, stability and protein folding. Our functional screen of 31 UBE3A missense mutants revealed that UBE3A mislocalization is the predominant cause of UBE3A dysfunction, accounting for 55% of the UBE3A mutations tested. The second major cause (29%) is a loss of E3-ubiquitin ligase activity, as assessed in an Escherichia coli in vivo ubiquitination assay. Mutations affecting catalytic activity are found not only in the catalytic HECT domain, but also in the N-terminal half of UBE3A, suggesting an important contribution of this N-terminal region to its catalytic potential. Together, our results show that loss of nuclear UBE3A E3 ligase activity is the predominant cause of UBE3A-linked AS. Moreover, our functional analysis screen allows rapid assessment of the pathogenicity of novel UBE3A missense variants which will be of particular importance when treatments for AS become available.

22 June 2017 in Pediatric and Developmental Pathology
Verified
Journal Article
Closed access
JAJane E Armes
Jane E Armes
MWMark Williams
Mark Williams
GPGareth Price
Gareth Price
TWTristan Wallis
Tristan Wallis
RGRenee Gallagher
Renee Gallagher
DVDeon J Venter
Deon J Venter
Death in the fetal, perinatal, and early infant age-group has a multitude of causes, a proportion of which is presumed to be genetic. Defining a specific genetic aberration leading to the death is problematic at this young age, due to limited phenotype–genotype correlation inherent in the underdeveloped phenotype, the inability to assess certain phenotypic traits after death, and the problems of dealing with rare disorders. In this study, our aim was to increase the yield of identification of a defined genetic cause of an early death. Therefore, we employed whole genome sequencing and bioinformatic filtering techniques as a comprehensive, unbiased genetic investigation into 16 fetal, perinatal, and early infant deaths, which had undergone a full autopsy. A likely genetic cause was identified in two cases (in genes; COL2A1 and RYR1) and a speculative genetic cause in a further six cases (in genes: ARHGAP35, BBS7, CASZ1, CRIM1, DHCR7, HADHB, HAPLN3, HSPG2, MYO18B, and SRGAP2). This investigation indicates that whole genome sequencing is a significantly enabling technology when determining genetic causes of early death.